Results 101 to 110 of about 116,811 (268)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Segregation and phase transformations at interfaces

open access: yes, 2004
Wichtige Eigenschaften metallischer Werkstoffe werden vom Verhalten der Grenzflächen, wie z.B. Korngrenzen und freien Oberflächen, stark beeinflusst. Das Verständnis von Vorgängen, die dieses Verhalten ändern können, gewinnen deswegen sowohl aus theoretischer als auch aus praktischer Sicht immer mehr an Bedeutung.
openaire   +2 more sources

The Effect of Cooling Rate on Crystallographic Features of Phase Transformations in Zr-2.5Nb. [PDF]

open access: yesMaterials (Basel), 2023
Lobanov ML   +6 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

THE INFLUENCE OF PRE-HEAT TREATMENT ON WHITE CAST IRONS PLASTICITY

open access: yesNauka ta progres transportu, 2013
Purpose. The development of heat treatment modes of white cast irons for structure changes in their eutectic constituent, namely in disturbing the monolithic structure of ledeburite colonies cementite structure and eutectic net continuity.
T. M. Myronova
doaj  

Phase transformations and vibrational properties of hybrid organic-inorganic perovskite MAPbI3 bulk at high pressure. [PDF]

open access: yesSci Rep, 2023
Ardimas   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy